drug
as of 2026-07-01ReMindCare Intervention Group
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by Instituto de Investigacion Sanitaria INCLIVA
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
DEVICE
Indications
Trials
1
ReMindCare App for Patients From First Episode of Psychosis Unit.
NCT03807388—Unknown
KOLs & investigators
1
Julio SanjuánKOL score 8
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here